Laser and Therapeutic Ultrasound in the Management of the Chronic Non-specific Low Back Pain

May 25, 2014 updated by: Ana Paula Fernandes A. Rubira, University of Sao Paulo General Hospital

Laser and and Ultrasound Effect on Pain and Disability in Women With Chronic Non-specific Low Back Pain: a Randomized Controlled Trial

The objective of this study is evaluate the laser and ultrasound effect on pain and disability in women with non-specific chronic low back pain.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

150

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Rondônia
      • Porto Velho, Rondônia, Brazil, 76804070
        • Sâo Lucas College

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • non-specific chronic low back pain
  • moderate pain
  • eutrophics women

Exclusion Criteria:

  • disk herniation
  • cardiac diseases
  • psychiatrics diseases
  • endocrinous diseases
  • fractures of the spine
  • fractures of lower members
  • diabetics
  • dental emergency
  • local infections
  • local non sensibility
  • analgesics and anti-inflammatories in use
  • neurologic diseases
  • pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Continuous ultrasound group
the group will be treated with 1,5 W/cm² 6 minutes in each side of the lumbar spine in 6 points around the lumbar spine
the group will be treated with 1,5 W/cm² 6 minutes in each side of the lumbar spine in 6 points around the lumbar spine
Other Names:
  • Sonopulse III
  • Ibramed
  • 1 MHz and 3 MHz of frequency
the group will be treated with 3 J 6 minutes in each side of the lumbar spine in 6 points around the lumbar spine
Other Names:
  • Ibramed
  • Laserpulse
  • 904 nm
Active Comparator: Pulsed ultrasound group
the group will be treated with 1,5 W/cm² 6 minutes in each side of the lumbar spine in 6 points around the lumbar spine
the group will be treated with 3 J 6 minutes in each side of the lumbar spine in 6 points around the lumbar spine
Other Names:
  • Ibramed
  • Laserpulse
  • 904 nm
the group will be treated with 1,5 W/cm² 6 minutes in each side of the lumbar spine in 6 points around the lumbar spine
Other Names:
  • Sonopulse III
  • Ibramed
  • 1 MHz and 3 MHz of frequency
Active Comparator: low level laser therapy group
the group will be treated with 3J during 6 minutes in each side of the lumbar spine in 6 points around the lumbar spine
the group will be treated with 1,5 W/cm² 6 minutes in each side of the lumbar spine in 6 points around the lumbar spine
Other Names:
  • Sonopulse III
  • Ibramed
  • 1 MHz and 3 MHz of frequency
the group will be treated with 1,5 W/cm² 6 minutes in each side of the lumbar spine in 6 points around the lumbar spine
Other Names:
  • Sonopulse III
  • Ibramed
  • 1 MHz and 3 MHz of frequency
No Intervention: control group
group of women no treated, only evaluated in two moments and this group will be compared with orthers: laser, pulsed ultrasound and continuous ultrasound.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain evaluation
Time Frame: The pain will be evaluate before and after 25 days of the treatment
The visual analogic scale will be used for evaluate the pain.
The pain will be evaluate before and after 25 days of the treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Disability evaluation
Time Frame: The disability will be evaluate before and after 25 days of the treatment
The Roland Morris questionaire will be used to evaluate the disability.
The disability will be evaluate before and after 25 days of the treatment

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Multidimensional evaluation of pain
Time Frame: The multidimensional evaluation of pain will be realized before and after 25 days of the treatment
The McGill questionaire will be used for the evaluation.
The multidimensional evaluation of pain will be realized before and after 25 days of the treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: ANA PAULA RUBIRA, MASTER, Sao Paulo University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2014

Primary Completion (Actual)

May 1, 2014

Study Completion (Anticipated)

July 1, 2014

Study Registration Dates

First Submitted

March 7, 2014

First Submitted That Met QC Criteria

May 25, 2014

First Posted (Estimate)

May 29, 2014

Study Record Updates

Last Update Posted (Estimate)

May 29, 2014

Last Update Submitted That Met QC Criteria

May 25, 2014

Last Verified

May 1, 2014

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CEP 390/10

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Low Back Pain

Clinical Trials on pulsed ultrasound group

Subscribe